Clinical and molecular factors for selection of nivolumab...

Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer

Ishii, Takahiro, Kawazoe, Akihito, Sasaki, Akinori, Mishima, Saori, Kentaro, Sawada, Nakamura, Yoshiaki, Kotani, Daisuke, Kuboki, Yasutoshi, Taniguchi, Hiroya, Kojima, Takashi, Doi, Toshihiko, Yoshino
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920942377
Date:
January, 2020
File:
PDF, 841 KB
2020
Conversion to is in progress
Conversion to is failed